Fig. 5

YQHX protected against injury induced by ischemia/hypoxia in H9c2 cardiomyocytes. a Effects of YQHX (100–400 μg/mL) on H9c2 cell viability at different time-points in normal conditions. b Effects of YQHX (100–400 μg/mL) treatment on H9c2 cell viability subjected to I/H at different time-points. Values were represented as mean ± SD (n = 6). ^*P < 0.05, ^**P < 0.01, ^***P < 0.001 versus control; ^#P < 0.05, ^##P < 0.01 versus hypoxia